May 31, 2019
THURSDAY, May 30, 2019 (CNN)—Girls began queuing at their local school with their friends, waiting for their names to be called. Many were apprehensive. After all, most of them had not had a vaccination since they were babies. It was 2013 and a new vaccine had arrived in Kanyirabanyana, a village in the Gakenke district of Rwanda.
Three years before, Rwanda had decided to make preventing cervical cancer a health priority. The government agreed a partnership with pharmaceutical company Merck to offer Rwandan girls the opportunity to be vaccinated against human papillomavirus (HPV), which causes cervical cancer.
Colon Cancer Striking More Under 50, and More Often in Western States
May 29, U.S. News & World Report
Alex Trebek faced grim chances of surviving cancer. Now he says it’s in ‘near remission.’
May 29, The Washington Post